Gary Clark: Unfiltered

K-Era Fest isn't just a cultural celebration—it's a calculated B2B maneuver positioning Seattle as the new gateway for Korean commerce in the US.

Presto Phoenix is partnering with Toast to bring Voice AI to the drive-thru. But behind the PR lies a grueling corporate restructuring and a fierce POS war.

Wall Street spent billions on AI chips, but forgot the power cord. Gary Clark breaks down how Liberty Mutual is cashing in on the grid bottleneck.

Westgate Energy’s upsized bought deal reveals how junior operators leverage frictionless capital and multilateral drilling to outpace equity dilution.

With the SEC turning minor tagging errors into automated filing suspensions, small-cap issuers must embrace parallel processing and legal ethics to survive.

Gary Clark dissects how a modular sofa startup's shift to physical showrooms reveals the survival strategy for modern direct-to-consumer brands.

BabyDoge's acquisition of LimeWire isn't just nostalgia. It's a strategic play to fuse a meme army with a legacy brand to challenge Big Tech's creator economy.

As AI makes translation a commodity, Lokalise's new no-code platform, Vantage, aims to redefine the game by empowering marketers to achieve cultural resonance.

A dead car battery is more than an inconvenience; it's a costly cascade of failures. We break down the warning signs and the true financial risks of neglect.

Joyce University's new, faster nursing degree challenges the 120-credit standard. Is this the innovation healthcare needs or a risky bet on efficiency?

Union Power Metals is drilling at a historic Slovakian site, hoping old data reveals a new source of battery-grade manganese for the EU's vulnerable supply chain.

Supply is at a 6-year high, giving buyers leverage. But with record prices and high rates, the market is splitting into hot and cold zones. Here's the story.

Brennan Investment Group's new 210,000 sq-ft facility isn't just another warehouse; it's a high-stakes bet on the enduring strength of Nashville's logistics market.

As the UAE's January 2027 e-invoicing mandate looms, a new partnership signals a fundamental shift in compliance strategy. It's no longer just about software.

After 80 years of ruling the home, Dearfoams is stepping outside. A deep dive into its MarshMELLOW launch and the high-stakes battle against Hoka and Crocs.

Fresh from bankruptcy, iRobot launches its most advanced Roomba. But in a market swamped by rivals, is this high-tech offensive enough to reclaim its throne?

A new wave of at-home neuromodulation devices is dismantling old treatment paradigms. We explore the shift from clinic to living room and what it means for patients and investors.

A deal in Georgia reveals the hidden truth of the AI boom: it's not just about chips, it's about keeping them cool. This is the story behind the numbers.

ElevateBio's new COO, Steven Falcone, is a strategic weapon against the crushing cost of advanced therapy manufacturing. This isn't just a hire; it's a war on the price of miracles.

Beyond the pink ribbons, the CIBC Run for the Cure is a funding powerhouse. We unpack the 30-year alliance that's fueling AI-driven diagnostics and policy battles.